« Natural Product Fragments: Get Rid of the Ugly Ones Now |
| Selective Inhibitor, The Catalog Says »
February 26, 2013
Standard of Care? Not So Fast, Not in the United Kingdom
Did you know that in the UK, patent law says that using a competitor's compound as a comparison in a clinical trial is an infringement? I sure didn't. The government has realized that this rule is much stricter than most other countries, and is moving to change it in a bid to keep more clinical research in the country. Thanks to FierceBiotech for the heads-up on this.
+ TrackBacks (0) | Category: Patents and IP
POST A COMMENT
- RELATED ENTRIES
- XKCD on Protein Folding
- The 2014 Chemistry Nobel: Beating the Diffraction Limit
- German Pharma, Or What's Left of It
- Sunesis Fails with Vosaroxin
- A New Way to Estimate a Compound's Chances?
- Meinwald Honored
- Molecular Biology Turns Into Chemistry
- Speaking at Northeastern